GR900300149T1 - Pharmaceutical and/or dietetical compositions containing l-carnitine and l-lysine - Google Patents

Pharmaceutical and/or dietetical compositions containing l-carnitine and l-lysine

Info

Publication number
GR900300149T1
GR900300149T1 GR90300149T GR900300149T GR900300149T1 GR 900300149 T1 GR900300149 T1 GR 900300149T1 GR 90300149 T GR90300149 T GR 90300149T GR 900300149 T GR900300149 T GR 900300149T GR 900300149 T1 GR900300149 T1 GR 900300149T1
Authority
GR
Greece
Prior art keywords
carnitine
lysine
pharmaceutical
dietetical
compositions containing
Prior art date
Application number
GR90300149T
Other languages
Greek (el)
English (en)
Inventor
Henri Laborit
Original Assignee
Bellon Labor Sa Roger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bellon Labor Sa Roger filed Critical Bellon Labor Sa Roger
Publication of GR900300149T1 publication Critical patent/GR900300149T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
GR90300149T 1988-08-12 1991-09-27 Pharmaceutical and/or dietetical compositions containing l-carnitine and l-lysine GR900300149T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8810886A FR2635264B1 (fr) 1988-08-12 1988-08-12 Compositions pharmaceutiques et/ou dietetiques contenant de la l-carnitine et de la l-lysine

Publications (1)

Publication Number Publication Date
GR900300149T1 true GR900300149T1 (en) 1991-09-27

Family

ID=9369324

Family Applications (2)

Application Number Title Priority Date Filing Date
GR90300149T GR900300149T1 (en) 1988-08-12 1991-09-27 Pharmaceutical and/or dietetical compositions containing l-carnitine and l-lysine
GR920403006T GR3006598T3 (enExample) 1988-08-12 1992-12-21

Family Applications After (1)

Application Number Title Priority Date Filing Date
GR920403006T GR3006598T3 (enExample) 1988-08-12 1992-12-21

Country Status (10)

Country Link
EP (2) EP0354848B1 (enExample)
JP (1) JP2785989B2 (enExample)
AT (1) ATE82122T1 (enExample)
CA (1) CA1341260C (enExample)
DE (2) DE68903448T2 (enExample)
ES (1) ES2043062T3 (enExample)
FR (1) FR2635264B1 (enExample)
GR (2) GR900300149T1 (enExample)
PT (1) PT91430B (enExample)
WO (1) WO1990001316A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660557B1 (fr) * 1990-04-09 1994-05-27 Endobio Groupe Etu Rech Risqu Compositions pharmaceutiques et/ou dietetiques contenant de la carnitine, de la lysine et de la methionine avec ou sans acide pantothenique.
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
IT1306147B1 (it) 1999-05-28 2001-05-30 Biosalts Srl Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
IT1306186B1 (it) 1999-09-03 2001-05-30 Biosalts Srl Sali non igroscopici di principi attivi ad attivita' terapeutica e/onutrizionale e composizioni atte alla somministrazione orale
IT1317042B1 (it) * 2000-06-14 2003-05-26 Biosalts Srl Fumarati doppi di una carnitina e creatina, e integratori alimentari,dietetici e farmaci che li contengono.
JP6766044B2 (ja) * 2015-07-01 2020-10-07 株式会社明治 継粉形成抑制剤
AU2018258250A1 (en) * 2017-04-25 2019-12-12 Almeda Labs Llc Amino acid formulations for pancreatic viability

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4465M (enExample) * 1965-06-28 1966-09-26
FR2119882A1 (en) * 1970-12-31 1972-08-11 Prugnaud Robert Calcium hypophosphite-ascorbate/carnitine compsn - used as appetite stimulant
US3968241A (en) * 1972-11-06 1976-07-06 Defelice Stephen L Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
IT1120033B (it) * 1979-10-05 1986-03-19 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion

Also Published As

Publication number Publication date
DE68903448T2 (de) 1993-03-18
JPH04500073A (ja) 1992-01-09
CA1341260C (fr) 2001-06-19
FR2635264B1 (fr) 1992-02-28
JP2785989B2 (ja) 1998-08-13
EP0354848B1 (fr) 1992-11-11
PT91430A (pt) 1990-03-08
WO1990001316A1 (fr) 1990-02-22
ATE82122T1 (de) 1992-11-15
GR3006598T3 (enExample) 1993-06-30
DE354848T1 (de) 1992-05-21
EP0354848A1 (fr) 1990-02-14
FR2635264A1 (fr) 1990-02-16
EP0428608A1 (fr) 1991-05-29
ES2043062T3 (es) 1993-12-16
DE68903448D1 (de) 1992-12-17
PT91430B (pt) 1995-05-31

Similar Documents

Publication Publication Date Title
US5091171B1 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
KR840003414A (ko) 3-히드록시부탄산 또는 이 산으로부터 유도된 염을 함유하는 약학적 조성물과, 의약품으로 사용할 수 있는 3-히드록시부탄산으로부터 유도된 화합물
PT787489E (pt) Composicao contendo propionil-l-carnitina e acido hidroxicitrico ou acido pantotenico
PT614616E (pt) Composicao para o tratamento de pacientes com doenca hepatica
IT1291113B1 (it) Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
ATE210977T1 (de) Pharmazeutische zusammensetzung enthaltend ein alkanoyl-l-carnitin in kombination mit einer polyungesättigten fettsäure der omega-3-serie zur verhütung und behandlung von störungen des fettstoffwechsels
ATE129894T1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
PT1216041E (pt) Dieta com elevado teor de lipidos
ES8106513A1 (es) Procedimiento para la preparacion de sales de la (+)-cate- quina
ATE65397T1 (de) Pharmazeutische zusammensetzungen mit gehalt an einem derivat der 3-hydroxy-buttersaeure, ausgewaehlt aus den oligomeren dieser saeure und den estern dieser saeure oder dieser oligomere mit dem 1,3-butan-diol.
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
GR900300149T1 (en) Pharmaceutical and/or dietetical compositions containing l-carnitine and l-lysine
DE3366838D1 (en) Pharmaceutical composition
PT95212A (pt) Processo para a preparacao de uma composicao para uso topico para o tratamento da fragilidade capilar, contendo defibrotide
FI934082A0 (fi) Kitosanbaserade naerings- och laekemedelskompositioner foer idisslare
DK0553581T3 (da) Transparente amorfe sammensætninger med høj bestandighed over for kemiske stoffer
ZA846425B (en) Benzoic acid derivatives process for preparation and application as drugs,disinfectants or preservatives
DE69133387D1 (de) Verwendung von Neotrehalose zur Herstellung eines Medikaments zur Energiesupplementierung bei einem lebenden Organismus
GB8516906D0 (en) Pharmaceutical & dietary composition
HU9202754D0 (en) N-substitutted amino-methane-diphosphonic acids
GT198500020A (es) 1,4-dihidropiridinlactonas 1-alquil-sustituidas, procedimiento para su obtencion y su empleo en medicamentos.
TH23727A (th) การยับยั้งเฮลิโคแบคเตอร์
IT1238688B (it) Composizioni galeniche adatte per la somministrazione nasale a base dieritropoietina,per il trattamento delle anemie